Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Ferring Pharms. Inc. v. Novel Labs., Inc., 17-0894 (D. Del.) July 5, 2017 Hon. Richard G. Andrews Prepopik® (sodium picosulfate / magnesium oxide / citric acid oral solution)
8,450,338
8,481,083
9,669,110
Sebela Int’l Ltd. V. Prinston Pharm. Inc., 17-4964 (D.N.J.) July 6, 2017 Hon. Claire C. Cecchi Brisdelle® (paroxetine capsules) 9,393,237
Mitsubishi Tanabe Pharma Corp. v. Aurobindo Pharma USA, Inc., 17-5005 (D.N.J.) July 7, 2017 Hon. Freda L. Wolfson Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Actelion Pharms. Ltd. v. Sun Pharm. Indus., Inc., 17-5015 (D.N.J.) July 7, 2017 Hon. Peter G. Sheridan Veletri® (epoprostenol sodium for injection) 8,598,227
Duke University v. Sandoz Inc., 17-0528 (E.D. Tex.) July 7, 2017 Hon. Rodney Gilstrap Latisse® (bimatoprost ophthalmic solution) 9,579,270
Dr. Reddy’s Labs., Inc. v. Icos Corp., IPR2017-01757 (PTAB) July 10, 2017 N/A Cialis® (tadalafil tablets) 6,943,166
KVK-Tech, Inc. v. Silvergate Pharms., Inc., PGR2017-00039 (PTAB) July 10, 2017 N/A Qbrelis® (lisinopril oral solution) 9,463,183
Eli Lilly and Co. v. MacLeods Pharma USA, Inc., 17-5087 (D.N.J.) July 12, 2017 Hon. Michael A. Shipp Cialis® (tadalafil tablets) 6,943,166
Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc., 17-5100 (D.N.J.) July 12, 2017 Hon. Jose L. Linares Narcan® (naloxone HCl nasal spray) 9,629,965
Argentum Pharms. LLC v. Icos Corp., IPR2017-01762 (PTAB) July 12, 2017 N/A Cialis® (tadalafil tablets) 6,943,166
Gilead Sciences, Inc. v. Amneal Pharms. LLC, 17-0943 (D. Del.) July 13, 2017 Vacant Judgeship (2017) Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
6,642,245
6,703,396
Par Pharm., Inc. v. Hospira, Inc., 17-0944 (D. Del.) July 13, 2017 Vacant Judgeship (2017) Adrenalin® (epinephrine for injection)
9,119,876
9,295,657
Mitsubishi Tanabe Pharma Corp. v. Prinston Pharms., Inc., 17-5135 (D.N.J.) July 13, 2017 Hon. Freda L. Wolfson Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Galderma Labs., L.P. v. Perrigo UK Finco Ltd., 17-1860 (N.D. Tex.) July 13, 2017 Hon. Barbara M.G. Lynn Soolantra® (ivermectin cream)
8,815,816
9,089,587
9,233,117
9,233,118
Par Pharm., Inc. v. Horizon therapeutics, Inc., IPR2017-01767 (PTAB) July 13, 2017 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 9,254,278
Par Pharm., Inc. v. Horizon therapeutics, Inc., IPR2017-01768 (PTAB) July 13, 2017 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 9,095,559
Par Pharm., Inc. v. Horizon therapeutics, Inc., IPR2017-01769 (PTAB) July 13, 2017 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 9,326,966
Biogen Int’l GMBH v. Zydus Pharms. (USA) Inc., 17-0954 (D. Del.) July 14, 2017 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules)
7,320,999
8,399,514
Delcor Asset Corp. v. Taro Pharm. Indus., Ltd., 17-0970 (D. Del.) July 17, 2017 Hon. Richard G. Andrews Evoclin® (clindamycin phosphate aerosol foam)
7,141,237
7,374,747
Delcor Asset Corp. v. Taro Pharm. Indus., Ltd., 17-5405 (S.D.N.Y.) July 17, 2017 Hon. Richard J. Sullivan Evoclin® (clindamycin phosphate aerosol foam)
7,141,237
7,374,747
Epic Pharma, LLC v. Pfizer Inc., 17-0987 (D. Del.) July 19, 2017 Hon. Gregory M. Sleet Zithromax® (azithromycin oral suspension) 6,268,489
Mitsubishi Tanabe Pharma Corp. v. Apotex, Inc., 17-5278 (D.N.J.) July 19, 2017 Hon. Freda L. Wolfson Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Mitsubishi Tanabe Pharma Corp. v. Apotex, Inc., 17-0990 (D. Del.) July 20, 2017 Hon. Gregory M. Sleet Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Mitsubishi Tanabe Pharma Corp. v. MSN Labs. Private Ltd., 17-5302 (D.N.J.) July 20, 2017 Hon. Freda L. Wolfson Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Celgene Corp. v. Dr. Reddy’s Labs., Ltd., 17-5314 (D.N.J.) July 20, 2017 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules)
7,189,740
8,404,717
9,056,120
Mitsubishi Tanabe Pharma Corp. v. Sandoz Inc., 17-5319 (D.N.J.) July 20, 2017 Hon. Michael A. Shipp Invokana® (canagliflozin tablets)
7,943,788
8,222,219
8,785,403
Precision Dermatology, Inc. v. Lupin Ltd., 17-5333 (D.N.J.) July 20, 2017 Hon. Peter G. Sheridan Locoid® (hydrocortisone butyrate lotion) 7,981,877
Mitsubishi Tanabe Pharma Corp. v. Sandoz Inc., 17-1781 (D. Col.) July 21, 2017 Hon. R. Brooke Jackson Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Mitsubishi Tanabe Pharma Corp. v. Sandoz Inc., 17-1782 (D. Col.) July 21, 2017 Hon. Kristen L. Mix Invokana® (canagliflozin tablets) 7,943,788
Mitsubishi Tanabe Pharma Corp. v. Teva Pharms. USA, Inc., 17-0998 (D. Del.) July 21, 2017 Hon. Gregory M. Sleet Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Bristol-Myers Squibb Co. v. Zydus Pharms. (USA) Inc., 17-5337 (D.N.J.) July 21, 2017 Hon. Peter G. Sheridan Reyataz® (atazanavir sulfate capsules) 6,087,383
Merck Sharp & Dohme Corp. v. Apotex Inc., 17-5399 (D.N.J.) July 24, 2017 Hon. Peter G. Sheridan Emend® (fosaprepitant dimeglumine for injection) 5,691,336
Takeda Pharms. U.S.A., Inc. v. Granules Pharms. Inc., 17-1019 (D. Del.) July 25, 2017 Hon. Richard G. Andrews Colcrys® (colchicine tablets)
7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Takeda Pharms. U.S.A., Inc. v. Hetero Labs Ltd., 17-1020 (D. Del.) July 25, 2017 Hon. Richard G. Andrews Colcrys® (colchicine tablets)
7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Bayer AG v. Mayne Pharma LLC, 17-1037 (D. Del.) July 27, 2017 Hon. Leonard P. Stark Natazia® (estradiol valerate / dienogest tablets) 8,071,577
Gilead Sciences, Inc. v. Macleods Pharms., Ltd., 17-1039 (D. Del.) July 27, 2017 Vacant Judgeship (2017) Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
6,642,245
6,703,396
8,592,397
8,716,264
9,457,036
Jazz Pharms., Inc. v. Ascent Pharms., Inc., 17-5487 (D.N.J.) July 27, 2017 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
6,472,431
6,780,889
7,262,219
7,851,506
8,263,650
8,324,275
8,461,203
7,668,730
7,765,106
7,765,107
7,895,059
8,457,988
8,589,182
8,731,963
8,772,306
8,859,619
8,952,062
9,539,330
9,486,426
9,050,302
Jazz Pharms., Inc. v. Ascent Pharms., Inc., 17-4439 (E.D.N.Y.) July 27, 2017 Hon. Pamela K. Chen Xyrem® (sodium oxybate oral solution)
6,472,431
6,780,889
7,262,219
7,851,506
8,263,650
8,324,275
8,461,203
7,668,730
7,765,106
7,765,107
7,895,059
8,457,988
8,589,182
8,731,963
8,772,306
8,859,619
8,952,062
9,539,330
9,486,426
9,050,302
Bayer Intellectual Property GMBH v. Lupin Ltd., 17-1047 (D. Del.) July 28, 2017 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Allergan, Inc. v. Taro Pharms., Inc., 17-1048 (D. Del.) July 28, 2017 Vacant Judgeship (2017) Aczone® (dapsone gel) 9,517,219
Endo Pharms. Inc. v. Lupin Atlantis Holdings SA, 17-0558 (E.D. Tex.) July 28, 2017 Hon. Rodney Gilstrap Nascobal® (cyanocobalamin nasal spray)
7,229,636
7,404,489
7,879,349
8,003,353
8,940,714
9,415,007
AstraZeneca LP v. Invagen Pharms. Inc., 17-1073 (D. Del.) Aug. 2, 2017 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
RE 46,276
7,250,419
7,265,124
Insys Therapeutics, Inc. v. Endo Generics Holdings, Inc., 17-1078 (D. Del.) Aug. 3, 2017 Hon. Leonard P. Stark Syndros® (dronabinol oral solution)
8,222,292
9,345,771
Horatio Washington Depot Technologies LLC v. Tolmar, Inc., 17-1086 (D. Del.) Aug. 3, 2017 Hon. Leonard P. Stark Eligard® (leuprolide acetate for injection)
5,932,547
6,124,261
6,235,712
Fresenius-Kabi USA LLC v. AstraZeneca AB, IPR2017-01910 (PTAB) Aug. 4, 2017 N/A Faslodex® (fulvestrant for injection) 6,774,122
Fresenius-Kabi USA LLC v. AstraZeneca AB, IPR2017-01912 (PTAB) Aug. 4, 2017 N/A Faslodex® (fulvestrant for injection) 8,466,139
Fresenius-Kabi USA LLC v. AstraZeneca AB, IPR2017-01913 (PTAB) Aug. 4, 2017 N/A Faslodex® (fulvestrant for injection) 8,329,680
Insys Therapeutics, Inc. v. Endo Generics Holdings, Inc., 17-5955 (S.D.N.Y.) Aug. 7, 2017 Hon. William H. Pauley, III Syndros® (dronabinol oral solution)
8,222,292
9,345,771
Horizon Therapeutics, LLC v. Lupin Ltd., 17-5900 (D.N.J.) Aug. 8, 2017 Hon. Kevin McNulty Ravicti® (glycerol phenylbutyrate oral liquid) 9,561,197
Horizon Therapeutics, LLC v. Par Pharm., Inc., 17-5901 (D.N.J.) Aug. 8, 2017 Hon. Kevin McNulty Ravicti® (glycerol phenylbutyrate oral liquid) 9,561,197
Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp., 17-5914 (D.N.J.) Aug. 8, 2017 Hon. Stanley R. Chesler Lantus® (insulin glargine injection)
7,476,652
7,713,930
Bayer Intellectual Property GMBH v. Breckenridge Pharm., Inc., 17-1129 (D. Del.) Aug. 11, 2017 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Purdue Pharma L.P. v. Alvogen Pine Brook, LLC, 17-1131 (D. Del.) Aug. 11, 2017 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,669,023
9,669,024
9,675,610
9,675,611
9,682,077
Aptalis Pharma US, Inc. v. Amneal Pharms. LLC, 17-1134 (D. Del.) Aug. 11, 2017 Hon. Leonard P. Stark Canasa® (mesalamine rectal suppository)
7,541,384
8,217,083
8,436,051
Aptalis Pharma US, Inc. v. Amneal Pharms. LLC, 17-6090 (D.N.J.) Aug. 11, 2017 Hon. Claire C. Cecchi Canasa® (mesalamine rectal suppository)
7,541,384
8,217,083
8,436,051
Eli Lilly and Co. v. Eagle Pharms., Inc., 17-2772 (S.D. Ind.) Aug. 14, 2017 Hon. Tanya Walton Pratt Alimta® (pemetrexed for injection) 7,772,209
Celgene Corp. v. Cipla Ltd., 17-6163 (D.N.J.) Aug. 15, 2017 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules)
7,465,800
7,855,217
7,968,569
8,530,498
8,648,095
9,101,621
9,101,622
Actavis Elizabeth LLC v. Novartis A.G., IPR2017-01946 (PTAB) Aug. 15, 2017 N/A Gilenya® (fingolimod capsules) 9,187,405
Cephalon, Inc. v. Slayback Pharma LLC, 17-1154 (D. Del.) Aug. 16, 2017 Hon. Gregory M. Sleet Bendeka® (bendamustine HCl for injection) 8,791,270
Sun Pharm. Indus., Ltd. v. Novartis A.G., IPR2017-01929 (PTAB) Aug. 16, 2017 N/A Gilenya® (fingolimod capsules) 9,187,405
Onyx Therapeutics, Inc. v. Innopharma Inc., 17-1155 (D. Del.) Aug. 17, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection)
7,232,818
7,491,704
8,129,346
8,207,125
8,207,126
8,207,127
Kissei Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 17-1161 (D. Del.) Aug. 18, 2017 Hon. Leonard P. Stark Rapaflo® (silodosin capsules) 5,387,603
Bayer Intellectual Property GMBH v. Torrent Pharms., Ltd., 17-1163 (D. Del.) Aug. 18, 2017 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Teva Pharms. Int’l GMBH v. Apotex Inc., 17-1164 (D. Del.) Aug. 18, 2017 Hon. Gregory M. Sleet Bendeka® (bendamustine HCl for injection)
8,791,270
8,609,707
9,265,831
9,572,796
9,572,797
9,034,908
9,144,568
9,572,887
9,597,397
9,597,398
9,597,399
9,000,021
9,579,384
Eli Lilly and Co. v. Jiangsu Hansoh Pharm. Group Co., Ltd., 17-2864 (S.D. Ind.) Aug. 21, 2017 Hon. Richard L. Young Alimta® (pemetrexed disodium for injection) 7,772,209
Eli Lilly and Co. v. Apotex, Inc., 17-2865 (S.D. Ind.) Aug. 21, 2017 Hon. Tanya Walton Pratt Alimta® (pemetrexed for injection) 7,772,209
Mitsubishi Tanabe Pharma Corp. v. Invagen Pharms., Inc., 17-6375 (D.N.J.) Aug. 23, 2017 Hon. Freda L. Wolfson Invokamet® (metformin HCl tablets) 7,943,788
Abbvie Inc. v. Macleods Pharms., Ltd., 17-1199 (D. Del.) Aug. 24, 2017 Hon. Richard G. Andrews Kaletra® (lopinavir / ritonavir tablets)
7,148,359
7,364,752
8,025,899
8,268,349
8,309,613
8,377,952
8,399,015
8,470,347
8,691,878
Teva Pharms. Int’l GMBH v. Fresenius Kabi USA, LLC, 17-1201 (D. Del.) Aug. 24, 2017 Hon. Gregory M. Sleet Bendeka® (bendamustine HCl for injection)
8,791,270
8,609,707
9,265,831
9,572,796
9,572,797
9,034,908
9,144,568
9,572,887
9,597,397
9,597,398
9,597,399
9,000,021
9,579,384
Onyx Therapeutics, Inc. v. Apotex Inc., 17-1202 (D. Del.) Aug. 24, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection)
7,417,042
7,232,818
7,491,704
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Mylan Pharms. Inc. v. Pozen Inc., IPR2017-01995 (PTAB) Aug. 24, 2017 N/A Vimovo® (esomeprazole magnesium / naproxen delayed-release tablets) 9,220,698
Forest Labs., LLC v. Aurobindo Pharma Ltd., 17-1210 (D. Del.) Aug. 25, 2017 Hon. Richard G. Andrews Linzess® (linaclotide capsules)
7,304,036
7,371,727
7,704,947
7,745,409
8,080,526
8,110,553
BTG Int’l Ltd. v. Teva Pharms. USA, Inc., 17-6435 (D.N.J.) Aug. 25, 2017 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Valeant Pharms. Int’l, Inc. v. Par Sterile Products, LLC, 17-6449 (D.N.J.) Aug. 25, 2017 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide for injection)
8,247,425
8,420,663
8,552,025
8,822,490
9,180,125
9,669,096
Valeant Pharms. Int’l, Inc. v. Par Sterile Products, LLC, 17-6557 (S.D.N.Y.) Aug. 28, 2017 Hon. Paul A. Engelmayer Relistor® (methylnaltrexone bromide for injection)
8,247,425
8,420,663
8,552,025
8,822,490
9,180,125
9,669,096
Onyx Therapeutics, Inc. v. Qilu Pharma, Inc., 17-1235 (D. Del.) Aug. 30, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection)
7,417,042
7,232,818
7,491,704
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Alcon Research, Ltd. v. Cipla Ltd., 17-1244 (D. Del.) Aug. 31, 2017 Hon. Gregory M. Sleet Pazeo® (olopatadine HCl ophthalmic solution)
8,791,154
9,533,053
Sanofi v. Aurobindo Pharma USA, Inc., 17-1247 (D. Del.) Aug. 31, 2017 Hon. Richard G. Andrews Multaq® (dronedarone tablets)
8,410,167
9,107,900
Valeant Pharms. Int’l, Inc. v. Mylan Pharms., Inc., 17-6714 (D.N.J.) Sept. 1, 2017 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide for injection) 9,669,096
Bristol-Myers Squibb Co. v. Emcure Pharms. Ltd., 17-6832 (D.N.J.) Sept. 6, 2017 Hon. Peter G. Sheridan Reyataz® (atazanavir sulfate capsules) 6,087,383
Celgene Corp. v. Lotus Pharm Co., Ltd., 17-6842 (D.N.J.) Sept. 6, 2017 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules)
5,635,517
6,315,720
6,561,977
6,755,784
7,189,740
7,465,800
7,855,217
7,968,569
8,315,886
8,404,717
8,530,498
8,626,531
8,648,095
9,056,120
9,101,621
9,101,622
Janssen Products, L.P. v. Aurobindo Pharma Ltd., 17-6872 (D.N.J.) Sept. 7, 2017 Hon. William H. Walls Prezista® (darunavir tablets)
8,518,987
7,700,645
7,126,015
7,595,408
Forest Labs., LLC v. Breckenridge Pharm., Inc., 17-1287 (D. Del.) Sept. 8, 2017 Hon. Mitchell S. Goldberg Saphris® (asenapine maleate tablets) 5,763,476
Allergan, Inc. v. Aurobindo Pharma Ltd., 17-1290 (D. Del.) Sept. 8, 2017 Hon. Gregory M. Sleet Lastacaft® (alcaftadine ophthalmic solution) 8,664,215
U.S. Dept. of Health and Human Services v. Aurobindo Pharma USA, Inc., 17-6911 (D.N.J.) Sept. 8, 2017 Hon. Michael A. Shipp Prezista® (darunavir tablets)
7,470,506
8,597,876
Merck Sharp & Dohme Corp. v. Teva Pharms. USA, Inc., 17-6921 (D.N.J.) Sept. 8, 2017 Hon. Michael A. Shipp Entereg® (alvimopan capsules)
6,469,030
8,946,262
Eli Lilly and Co. v. Eagle Pharms., Inc., 17-1293 (D. Del.) Sept. 11, 2017 Vacant Judgeship (2017) Alimta® (pemetrexed for injection) 7,772,209
Eli Lilly and Co. v. Glenmark Pharms. Ltd., 17-7024 (D.N.J.) Sept. 12, 2017 Hon. Katharine S. Hayden Cialis® (tadalafil tablets) 6,943,166
Insys Therapeutics, Inc. v. Teva Pharms. USA, Inc., 17-1303 (D. Del.) Sept. 13, 2017 Hon. Gregory M. Sleet Subsys® (fentanyl sublingual spray)
8,486,972
8,486,973
8,835,459
8,835,460
9,241,935
9,289,387
9,642,797
9,642,844
Sandoz Inc. v. Duke University, 17-0823 (M.D.N.C.) Sept. 14, 2017 Hon. Catherine C. Eagles Latisse® (bimatoprost ophthalmic solution) 9,579,270
Indivior Inc. v. Alvogen Pine Brook, Inc., 17-7106 (D.N.J.) Sept. 14, 2017 Hon. Kevin McNulty Suboxone® (buprenorphine HCl naloxone HCl sublingual film) 9,687,454
Indivior Inc. v. Dr. Reddy’s Labs. S.A., 17-7111 (D.N.J.) Sept. 14, 2017 Hon. Kevin McNulty Suboxone® (buprenorphine HCl naloxone HCl sublingual film) 9,687,454
Indivior Inc. v. Teva Pharms. USA, Inc., 17-7115 (D.N.J.) Sept. 14, 2017 Hon. Kevin McNulty Suboxone® (buprenorphine HCl naloxone HCl sublingual film) 9,687,454
Indivior Inc. v. Par Pharm., Inc., 17-7020 (S.D.N.Y.) Sept. 14, 2017 Hon. Katherine B. Forrest Suboxone® (buprenorphine HCl naloxone HCl sublingual film) 9,687,454
Indivior Inc. v. Actavis Labs. UT, Inc., 17-1034 (D. Utah) Sept. 14, 2017 Hon. Dustin B. Pead Suboxone® (buprenorphine HCl naloxone HCl sublingual film) 9,687,454
Indivior Inc. v. Mylan Technologies, Inc., 17-0157 (N.D.W.V.) Sept. 14, 2017 Hon. Irene M. Keeley Suboxone® (buprenorphine HCl naloxone HCl sublingual film) 9,687,454
Teijin Ltd. v. Aurobindo Pharma Ltd., 17-1314 (D. Del.) Sept. 15, 2017 Vacant Judgeship (2017) Uloric® (febuxostat tablets)
6,255,474
7,361,676
8,372,872
9,107,912
Forest Labs., LLC v. Prinston Pharm. Inc., 17-7191 (D.N.J.) Sept. 18, 2017 Hon. Brian R. Martinotti Byvalson® (nebivolol / valsartan tablets)
7,803,838
7,838,552
Valeant Pharms. Int’l, Inc. v. Actavis LLC, 17-7206 (D.N.J.) Sept. 18, 2017 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide for injection)
9,669,096
9,492,445
Purdue Pharma L.P. v. Par Pharm., Inc., 17-1334 (D. Del.) Sept. 20, 2017 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets)
9,492,389
9,492,391
9,492,392
9,492,393
Takeda Pharm. Co. Ltd. v. Indoco Remedies Ltd., 17-7301 (D.N.J.) Sept. 20, 2017 Hon. Stanley R. Chesler Nesina® (alogliptin benzoate tablets)
7,807,689
8,173,663
8,288,539
8,697,125
Purdue Pharma L.P. v. Par Pharm., Inc., 17-1582 (D. Conn.) Sept. 21, 2017 Hon. Stefan R. Underhill OxyContin® (oxycodone HCl extended-release tablets)
9,492,389
9,492,391
9,492,392
9,492,393
Purdue Pharma L.P. v. Collegium Pharm., Inc., 17-11814 (D. Mass.) Sept. 21, 2017 Hon. F. Dennis Saylor, IV
OxyContin® (oxycodone HCl extended-release tablets)
Xtampza® ER (oxycodone extended-release capsules)
9,693,961
Mitsubishi Tanabe Pharma Corp. v. Prinston Pharms., Inc., 17-7342 (D.N.J.) Sept. 21, 2017 Hon. Freda L. Wolfson Invokana® (canagliflozin tablets) 8,513,202
Shionogi Inc. v. Qingdao Baheal Pharm. Co. Ltd., 17-1347 (D. Del.) Sept. 22, 2017 Hon. Mitchell S. Goldberg Fortamet® (metformin extended-release tablets)
6,790,459
6,866,866
Sucampo AG v. Teva Pharm. Indus. Ltd., 17-7451 (D.N.J.) Sept. 25, 2017 Hon. Peter G. Sheridan Amitiza® (lubiprostone capsules)
6,414,016
8,071,613
7,795,312
6,982,283
8,097,653
8,389,542
8,026,393
8,338,639
8,748,481
Duke University v. Alembic Pharms., Ltd., 17-7453 (D.N.J.) Sept. 25, 2017 Hon. Brian R. Martinotti Latisse® (bimatoprost ophthalmic solution) 9,579,270
Biogen Int’l GMBH v. Teva Pharms. USA, Inc., 17-1361 (D. Del.) Sept. 27, 2017 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules)
6,509,376
7,320,999
Wyeth LLC v. Sun Pharm. Indus. Ltd., 17-1362 (D. Del.) Sept. 28, 2017 Hon. Richard G. Andrews Bosulif® (bosutinib tablets)
7,417,148
7,919,625

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.